Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

EBILFUMIN 75 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/EBILFUMIN 75 MG CAPSULAS DURAS EFG

Approved

STANDARD

EBILFUMIN 75 MG CAPSULAS DURAS EFG

Actavis Group Ptc Ehf.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 15, 2020
Approval ID: 044aba5010ab5795
Company: Actavis Group Ptc Ehf.
Type: Standard

Approval Details

Approval Id: 044aba5010ab5795
Drug Cima Aemps Name: EBILFUMIN 75 MG CAPSULAS DURAS EFG
Register Number: 1140915005
Holder Company Name: Actavis Group Ptc Ehf.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/actavis-group-ptc-ehf
Authorization Date: 2020-06-15
Dosage Form: CÁPSULA DURA
Dose: 75 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Actavis Group Ptc Ehf.
Company Detail Path: /organization/actavis-group-ptc-ehf

Company Information

Pharmaceutical Company Name: Actavis Group PTC ehf
Name En: Actavis Group PTC ehf
Country Name: Norway
City Name: lierskogen,buskerud,country_no
Address: c/o Actavis Norway AS Gjellebekkstubben 10

Active Ingredients

OSELTAMIVIR FOSFATO

98.5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 15, 2020

Approval ID

044aba5010ab5795

Type

Standard

Back to CIMA-AEMPS Approvals